Open menu Close menu Open Search Close search

Abreva Cream (Glaxosmithkline)

  • Indications and Usage
  • Description
  • Dosage and Administration
  • Warnings
  • How Supplied

    - Drugs index
    - Manufacturers
    - Feedback

  • Uses:

    • Treats cold sore/fever blisters on the face or lips
    • Shortens healing time and duration of symptoms: tingling, pain, burning, and/or itching

    Active Ingredient:                               Purpose:

    Docosanol 10%............................ Cold sore/fever blister treatment

    Inactive Ingredients:    Benzyl alcohol, light mineral oil, propylene glycol, purified water, sucrose distearate, sucrose stearate.


    • adults and children 12 years or over:
      • wash hands before and after applying cream
      • apply to affected area on face or lips at the first sign of cold sore/fever blister (tingle). Early treatment ensures the best results.
      • rub in gently but completely
      • use 5 times a day until healed
    • children under 12 years: ask a doctor


    For external use only.

    Do not use

    • if you are allergic to any ingredient in this product

    When using this product

    • apply only to affected areas
    • do not use in or near the eyes
    • avoid applying directly inside your mouth
    • do not share this product with anyone. This may spread infection.

    Stop use and ask a doctor if

    • your cold sore gets worse or the cold sore is not healed within 10 days
    • Keep out of reach of children. If swallowed, get medical help or contact a poison control center right away.

    Other Information:

    • store at 20°-25°C (68°-77°F)
    • do not freeze

    How Supplied:    Abreva Cream is supplied in 2.0 g [.07 oz] tubes.

    Question? Call 1-877-709-3539 weekdays

    - To bookmark this page (add it to your favorites), please click the image to the left.
    - If you wish to link to this page, you can do so by referring to the URL address below this line.

    This page was last modified 30-JUN-07
    Copyright © 1995-2021 ITA all rights reserved.